- Published on
Evidium Raises $22M in Funding
- Author
-
-
- Name
- Posts
- Posts
-
Evidium, a San Francisco, CA-based healthcare AI company, raised $22M in Funding.
The round was led by Health2047, and WGG Partners, with participation from x.AI, Perplexity, Innovaccer, Interwoven Ventures and Mindset Ventures.
The company intends to use the funds to accelerate product development, expands its clinical modeling capabilities, and scales go-to-market operations.
Led by CEO and Founder Carl Bate, Evidium provides a platform that offers multiple precision products, each addressing specific stakeholder needs. Its precision products today include quality insights for clinicians and care teams, as well as probabilistic forecasting for medical risk bearing organizations including insurers, health plans, and integrated delivery networks (“payviders”).
The company says that its products allow stakeholders to better understand each condition and the associated care journey and cost.
source[FinSMEs]
The round was led by Health2047, and WGG Partners, with participation from x.AI, Perplexity, Innovaccer, Interwoven Ventures and Mindset Ventures.
The company intends to use the funds to accelerate product development, expands its clinical modeling capabilities, and scales go-to-market operations.
Led by CEO and Founder Carl Bate, Evidium provides a platform that offers multiple precision products, each addressing specific stakeholder needs. Its precision products today include quality insights for clinicians and care teams, as well as probabilistic forecasting for medical risk bearing organizations including insurers, health plans, and integrated delivery networks (“payviders”).
The company says that its products allow stakeholders to better understand each condition and the associated care journey and cost.
source[FinSMEs]
0 Comments